Hospital Pharmacy Compounding against COVID-19 pandemic
As in other areas of the health system, COVID-19 has had a dramatic impact on hospital compounding. This area has faced numerous challenges, including the shortage of frequent-use products (hydroalcoholic solutions, lopinavir/ritonavir suspension), the use of new preparations for SARS-CoV-2 (tocil...
Saved in:
| Main Authors: | José María Alonso-Herreros, Silvia Berisa-Prado, Carme Cañete-Ramírez, María del Pilar Flox-Benítez, Margarita Ladrón de Guevara-García, Carmen López-Cabezas, Ana María Martín de Rosales-Cabrera, Beatriz Ramos-Martínez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2020-06-01
|
| Series: | Farmacia Hospitalaria |
| Subjects: | |
| Online Access: | http://www.aulamedica.es/fh/pdf/11492.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort
by: Dóra Paróczai, et al.
Published: (2025-01-01) -
Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report
by: Yue Sun, et al.
Published: (2025-02-01) -
Pharmacy Education and Clinical Pharmacy Training in France
by: Florence Ranchon, et al.
Published: (2024-10-01) -
Evaluation of specialized training in hospital pharmacy
by: María José Gimeno-Jordá, et al.
Published: (2020-09-01) -
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
by: Victoria Hendrick, et al.
Published: (2024-10-01)